Title: Accelerating
drug discovery process Publication: Biospectrum Date: 26 Mar 2012 URL: link
to website
Summary
·
LegoChem Biosciences is working on
faster and more efficient drug discovery and development of new small
molecules. ·
They enable discovery of new small
molecule drugs faster and more efficiently by combining their core technology,
LegoChemistry, with early absorption, distribution, metabolism, excretion and
toxicity (ADMET) screening platform technologies. ·
LegoChem Biosciences is committed to
building sustainable pipelines in therapeutic areas of antibiotics,
anti-coagulants, anti-cancer and antibody-drug conjugate (ADC) platform
technology. About LegoChem Biosciences LegoChem Biosciences, Inc. (LCB) is a
research-based biotechnology company dedicated to discovering, developing, and
commercializing innovative medicines by leveraging our chemistry expertise to
make conventional biologics targeted and more potent for the benefit of
patients with diseases of high unmet medical needs. We are advancing
sustainable pipelines in therapeutic areas in antibiotics, anti-coagulants,
oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).
| 
